Business · 16/07/2019Updated: 10/17/2026 · 1 min read
FDA Requests Public Comment on Proposed Collection of Information for Drug Labeling Guidance
The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to its guidance on drug labeling for cardiovascular outcome claims, specifically for drugs used to treat hypertension.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →